Market Price

278.12 

1.29 0.5%

as of Mar 21 '23

52 Week Range:

184.58 284.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 15.31
16.61
16.81
18.77
20.82
23.54
23.32
23.04
29.41
28.18
33.06
growth rate 8.5% 1.2% 11.7% 10.9% 13.1% -0.9% -1.2% 27.7% -4.2% 17.3%
Earnings BIT 1,303.33
1,318.75
933.15
1,735.00
1,921.00
2,063.00
2,894.00
3,398.00
2,943.00
3,655.00
growth rate 1.2% -29.2% 36.4% 10.7% 7.4% 40.3% 17.4% -13.4% 24.2%
Avg.PE 14.25
16.37
28.49
20.90
20.90
25.79
48.28
20.57
growth rate 14.9% 74.0% -26.6% 0.0% 23.4% 87.2% -19.2%
ROA 11.55
10.14
6.95
3.08
8.47
8.98
4.79
14.38
7.26
4.96
5.78
growth rate -12.2% -31.5% -55.7% 175.0% 6.0% -46.7% 200.2% -49.5% -31.7% 16.5%
ROE 18.11
15.95
11.40
5.84
16.82
18.24
10.45
32.75
16.98
12.35
14.26
growth rate -11.9% -28.5% -48.8% 188.0% 8.4% -42.7% 213.4% -48.2% -27.3% 15.5%
ROIC 15.24
13.10
9.08
4.22
11.47
11.36
6.06
18.33
9.16
6.27
7.33
growth rate -14.0% -30.7% -53.5% 171.8% -1.0% -46.7% 202.5% -50.0% -31.6% 16.9%
Cur. Ratio 3.94
4.34
3.14
2.17
2.27
2.50
2.29
2.02
2.58
1.93
2.20
growth rate 10.2% -27.7% -30.9% 4.6% 10.1% -8.4% -11.8% 27.7% -25.2% 14.0%
Quick Ratio 2.65
3.05
2.07
1.47
1.64
1.70
1.43
1.25
1.66
1.14
1.33
growth rate 15.1% -32.1% -29.0% 11.6% 3.7% -15.9% -12.6% 32.8% -31.3% 16.7%
Leverage 1.61
1.54
1.74
2.06
1.91
2.14
2.23
2.32
2.36
2.62
2.33
growth rate -4.4% 13.0% 18.4% -7.3% 12.0% 4.2% 4.0% 1.7% 11.0% -11.1%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 1,092.79
1,102.82
1,170.68
1,662.00
1,967.00
2,198.00
2,332.00
2,893.00
2,701.00
3,022.00
growth rate 0.9% 6.2% 19.2% 18.4% 11.7% 6.1% 24.1% -6.6% 11.9%
Acct.Payable 2,734.00
2,920.00
2,853.00
646.00
675.00
810.00
1,129.00
growth rate 6.8% -2.3% -77.4% 4.5% 20.0% 39.4%
Cur.Assets 5,558.04
6,283.74
6,427.95
7,943.00
7,861.00
7,993.00
9,733.00
11,058.00
9,707.00
10,017.00
growth rate 13.1% 2.3% 11.2% -1.0% 1.7% 21.8% 13.6% -12.2% 3.2%
Total Assets 9,367.00
10,184.47
12,141.00
16,223.00
20,435.00
22,197.00
27,229.00
30,167.00
34,330.00
34,631.00
growth rate 8.7% 19.2% 15.6% 26.0% 8.6% 22.7% 10.8% 13.8% 0.9%
Cash 697.94
1,075.82
1,032.64
3,379.00
3,316.00
2,542.00
3,616.00
4,337.00
2,943.00
2,944.00
growth rate 54.1% -4.0% 80.9% -1.9% -23.3% 42.3% 19.9% -32.1% 0.0%
Inventory 989.45
975.57
1,096.65
1,639.00
2,030.00
2,465.00
2,955.00
2,980.00
3,494.00
3,314.00
growth rate -1.4% 12.4% 22.3% 23.9% 21.4% 19.9% 0.9% 17.3% -5.2%
Cur.Liabilities 1,419.01
1,446.77
2,049.08
3,502.00
3,148.00
3,485.00
4,807.00
4,400.00
5,041.00
4,549.00
growth rate 2.0% 41.6% 30.7% -10.1% 10.7% 37.9% -8.5% 14.6% -9.8%
Liabilities 3,441.87
3,554.46
5,163.96
7,712.00
10,885.00
12,231.00
15,499.00
17,360.00
21,246.00
19,754.00
growth rate 3.3% 45.3% 22.2% 41.1% 12.4% 26.7% 12.0% 22.4% -7.0%
LT Debt 1,350.37
1,346.52
2,112.32
3,230.00
6,686.00
6,590.00
8,486.00
10,231.00
13,230.00
12,472.00
growth rate -0.3% 56.9% 23.7% 107.0% -1.4% 28.8% 20.6% 29.3% -5.7%
Equity 5,925.13
6,630.01
6,977.05
8,511.00
9,550.00
9,966.00
11,730.00
12,807.00
13,084.00
14,877.00
growth rate 11.9% 5.2% 10.5% 12.2% 4.4% 17.7% 9.2% 2.2% 13.7%
Common Shares 390.00
383.00
382.00
383.00
380.00
379.00
380.00
37.00
37.00
38.00
38.00
growth rate -1.8% -0.3% 0.3% -0.8% -0.3% 0.3% -90.3% 0.0% 2.7% 0.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 122.62
161.95
150.38
270.00
490.00
598.00
572.00
649.00
487.00
525.00
growth rate 32.1% -7.1% 34.0% 81.5% 22.0% -4.4% 13.5% -25.0% 7.8%
Cash Dividends 215.16
249.87
309.25
521.00
568.00
636.00
703.00
778.00
863.00
950.00
growth rate 16.1% 23.8% 29.8% 9.0% 12.0% 10.5% 10.7% 10.9% 10.1%
Cash From OA 1,105.90
1,277.88
1,454.48
981.00
1,915.00
1,559.00
2,610.00
2,191.00
3,277.00
3,263.00
growth rate 15.6% 13.8% -17.9% 95.2% -18.6% 67.4% -16.1% 49.6% -0.4%
FCF per Share 2.17
2.88
3.09
3.33
1.56
3.52
1.94
3.76
4.47
4.84
6.95
growth rate 32.7% 7.3% 7.8% -53.2% 125.6% -44.9% 93.8% 18.9% 8.3% 43.6%
Sale Purchase of Stock -700.00
-13.00
-329.00
growth rate 0.0% 0.0%
FCF 1,208.00
1,447.00
1,691.00
1,549.00
629.00
1,322.00
961.00
2,038.00
1,542.00
2,790.00
2,738.00
growth rate 19.8% 16.9% -8.4% -59.4% 110.2% -27.3% 112.1% -24.3% 80.9% -1.9%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 6,406.36
6,676.28
6,957.00
9,946.00
11,325.00
12,444.00
13,601.00
14,884.00
14,351.00
17,108.00
growth rate 4.2% 4.2% 19.6% 13.9% 9.9% 9.3% 9.4% -3.6% 19.2%
Op.Income 1,300.24
1,342.66
968.63
1,861.00
2,166.00
2,290.00
2,894.00
3,398.00
2,943.00
3,655.00
growth rate 3.3% -27.9% 38.6% 16.4% 5.7% 26.4% 17.4% -13.4% 24.2%
IBT 1,300.24
1,314.90
934.69
1,735.00
1,921.00
2,063.00
2,356.00
2,562.00
1,954.00
2,281.00
growth rate 1.1% -28.9% 36.2% 10.7% 7.4% 14.2% 8.7% -23.7% 16.7%
Net Income 1,037.26
1,001.02
775.83
1,439.00
1,647.00
1,020.00
3,553.00
2,083.00
1,599.00
1,994.00
growth rate -3.5% -22.5% 36.2% 14.5% -38.1% 248.3% -41.4% -23.2% 24.7%
EPS 3.45
3.39
2.63
1.34
3.78
4.35
2.68
9.34
5.48
4.20
5.21
growth rate -1.7% -22.4% -49.1% 182.1% 15.1% -38.4% 248.5% -41.3% -23.4% 24.1%
Gross Profit 4,238.52
4,531.57
4,661.13
6,602.00
7,495.00
8,173.00
8,981.00
9,801.00
9,158.00
11,262.00
growth rate 6.9% 2.9% 19.0% 13.5% 9.1% 9.9% 9.1% -6.6% 23.0%
R&D 356.29
363.24
413.36
625.00
715.00
787.00
862.00
971.00
984.00
1,235.00
growth rate 2.0% 13.8% 23.0% 14.4% 10.1% 9.5% 12.7% 1.3% 25.5%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 942.00
890.00
1,100.00
717.00
873.00
growth rate -5.5% 23.6% -34.8% 21.8%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 2,714.00
2,817.00
3,022.00
2,991.00
3,145.00
growth rate 3.8% 7.3% -1.0% 5.2%
Acct.Payable 864.00
934.00
1,129.00
1,084.00
1,160.00
growth rate 8.1% 20.9% -4.0% 7.0%
Cur.Assets 9,032.00
9,460.00
10,017.00
8,725.00
8,825.00
growth rate 4.7% 5.9% -12.9% 1.2%
Total Assets 33,698.00
34,145.00
34,631.00
36,137.00
36,032.00
growth rate 1.3% 1.4% 4.4% -0.3%
Cash 2,241.00
2,563.00
2,944.00
1,458.00
1,044.00
growth rate 14.4% 14.9% -50.5% -28.4%
Inventory 3,431.00
3,434.00
3,314.00
3,525.00
3,749.00
growth rate 0.1% -3.5% 6.4% 6.4%
Cur.Liabilities 4,252.00
4,449.00
4,549.00
4,408.00
4,404.00
growth rate 4.6% 2.3% -3.1% -0.1%
Liabilities 19,878.00
19,967.00
19,754.00
21,091.00
20,358.00
growth rate 0.5% -1.1% 6.8% -3.5%
LT Debt 12,734.00
12,629.00
12,472.00
13,885.00
13,374.00
growth rate -0.8% -1.2% 11.3% -3.7%
Equity 13,820.00
14,178.00
14,877.00
15,046.00
15,674.00
growth rate 2.6% 4.9% 1.1% 4.2%
Common Shares 38.00
38.00
38.00
38.00
38.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 106.00
130.00
206.00
119.00
143.00
growth rate 22.6% 58.5% -42.2% 20.2%
Cash Dividends 237.00
238.00
237.00
262.00
263.00
growth rate 0.4% -0.4% 10.6% 0.4%
Cash From OA 878.00
933.00
1,000.00
203.00
529.00
growth rate 6.3% 7.2% -79.7% 160.6%
Sale Purchase of Stock
growth rate
FCF 772.00
803.00
794.00
84.00
386.00
growth rate 4.0% -1.1% -89.4% 359.5%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 4,294.00
4,160.00
4,701.00
4,275.00
4,493.00
growth rate -3.1% 13.0% -9.1% 5.1%
Op.Income 942.00
890.00
1,100.00
717.00
873.00
growth rate -5.5% 23.6% -34.8% 21.8%
IBT 662.00
495.00
757.00
386.00
720.00
growth rate -25.2% 52.9% -49.0% 86.5%
Net Income 592.00
438.00
662.00
323.00
656.00
growth rate -26.0% 51.1% -51.2% 103.1%
EPS
growth rate
Gross Profit 2,832.00
2,756.00
3,088.00
2,741.00
2,841.00
growth rate -2.7% 12.1% -11.2% 3.7%
R&D 310.00
306.00
331.00
334.00
351.00
growth rate -1.3% 8.2% 0.9% 5.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (69.45)

YOY Growth Grade:

D (41.52)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 74.39 90.86 21.75
EPS / Growth 11.5% 3.06 13.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.3% 11.7% 11.7%
Future PE 20.50 22.58 22.58
Future EPS 8.12 9.26 9.26
Value Price
MOS %
41.16
-85.2%
51.71
-81.4%
51.71
-81.4%
MOS Price 20.58 25.86 25.86
IRT 23.01 21.24 21.24

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.